🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07533006
Recruiting Phase 2

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

NCT07533006 · tracked via the Priya Life Science China tracker
Sponsor
Eli Lilly and Company
Phase
Phase 2
Started
2026-04-14
Last updated
2026-09-08

Condition(s) studied

Alopecia Areata

Investigational drug(s) / intervention(s)

LY4005130Placebo

LY4005130: Administered IV

Placebo: Administered IV

Study summary

The purpose of this study is to evaluate how well LY4005130 works in participants with severe alopecia areata (hair loss) when compared with placebo, and how well it's tolerated and what side effects may occur. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.

The study drug will be administered intravenously (IV) (into a vein in the arm).

The study will last approximately 48 weeks, including screening.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Have severe Alopecia Areata (AA) that meets all of the following criteria: * Hair loss encompassing ≥50% and ≤90% of the scalp, as measured by Severity of Alopecia Tool (SALT) score * The duration of the current episode of severe AA is at least 6 months and does not exceed 4 years * No significant spontaneous hair regrowth in the investigator's opinion for at least 6 months * Agree not to use any AA treatments during the study Exclusion Criteria: * Primarily "diffuse" type of AA (characterized by diffuse hair shedding) * Are currently experiencing other forms of alopecia * Participants who, in the opinion of the investigator, are currently experiencing or have a history of unstable concomitant disease that requires frequent hospitalizations, and/or frequent use of systemic immunosuppressants that may interfere with participation in the study * Have received oral JAK Inhibitors in the past * Have had any major surgery within 8 weeks prior to screening or will require major surgery during the study * Have a history or presence of cardiovascular, respiratory, hepatic, gastrointestinal, endocrine, hematological, neurological, or neuropsychiatric disorders or any other serious and/or unstable illness

Primary outcome measure(s)

Trial sites (30)

FacilityCityRegionStatus
Center For Dermatology Clinical Research, Inc. Fremont California Recruiting
Northridge Clinical Trials Northridge California Recruiting
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway Santa Clarita California Recruiting
Health Clinical Research, LLC Cutler Bay Florida Recruiting
Brigham and Women's Hospital Boston Massachusetts Recruiting
Revival Research Institute, LLC Troy Michigan Recruiting
Stracskin Portsmouth New Hampshire Recruiting
Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue San Antonio Texas Recruiting
Jordan Valley Dermatology & Research Center South Jordan Utah Recruiting
Kelowna Health and Memory Centre Kelowna Canada Recruiting
Ryan Clinical Research Inc. Newmarket Canada Recruiting
Dar Clinical Research - Ottawa - Hunt Club Road Ottawa Canada Recruiting
SIMa Recherche Verdun Canada Not Yet Recruiting
Beijing Friendship Hospital Affiliate of Capital University Beijing China Not Yet Recruiting
Huashan Hospital, Fudan University Shanghai China Recruiting
Shanghai Skin Disease Hospital Shanghai China Recruiting
Tianjin Medical University General Hospital Tianjin China Not Yet Recruiting
Erasmus Medisch Centrum Rotterdam Netherlands Not Yet Recruiting
Centrum Badan Klinicznych PI-House sp. z o.o. Gdansk Poland Recruiting
Diamond Clinic Krakow Poland Recruiting
Dermedic Jacek Zdybski Ostrowiec Świętokrzyski Poland Recruiting
Centrum Medyczne Ginemedica Wroclaw Poland Recruiting
Chung-Ang University Hospital Dongjak-gu South Korea Not Yet Recruiting
Inha University Hospital Incheon South Korea Not Yet Recruiting
Jeonbuk National University Hospital Jeonju South Korea Not Yet Recruiting
Seoul National University Hospital Seoul South Korea Not Yet Recruiting
Kyung Hee University Hospital at Gangdong Seoul South Korea Not Yet Recruiting
Royal London Hospital London United Kingdom Recruiting
Chelsea and Westminster Hospital NHS Foundation Trust London United Kingdom Not Yet Recruiting
Salford Royal Hospital Salford United Kingdom Not Yet Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07533006 on ClinicalTrials.gov ↗ ← All trials in China